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CT colonography: optimisation, diagnostic
performance and patient acceptability
of reduced-laxative regimens
using barium-based faecal tagging
Abstract To establish the optimum
barium-based reduced-laxative tag-
ging regimen prior to CT colono-
graphy (CTC). Ninety-five subjects
underwent reduced-laxative (13 g
senna/18 g magnesium citrate) CTC
prior to same-day colonoscopy and
were randomised to one of four
tagging regimens using 20 ml 40%w/v
barium sulphate: regimen A: four
doses, B: three doses, C: three doses
plus 220 ml 2.1% barium sulphate, or
D: three doses plus 15 ml diatriazoate
megluamine. Patient experience was
assessed immediately after CTC and
1 week later. Two radiologists graded
residual stool (1: none/scattered to 4:
>50% circumference) and tagging
efficacy for stool (1: untagged to 5:
100% tagged) and fluid (1: untagged,
2: layered, 3: tagged), noting the HU
of tagged fluid. Preparation was good
(76–94% segments graded 1),
although best for regimen D (P=0.02).
Across all regimens, stool tagging
quality was high (mean 3.7–4.5) and
not significantly different among
regimens. The HU of layered tagged
fluid was higher for regimens C/D
than A/B (P=0.002). Detection of
cancer (n=2), polyps ≥6m m( n=21),
and≤5m m( n=72) was 100, 81 and
32% respectively, with only four false
positives ≥6 mm. Reduced preparation
was tolerated better than full endo-
scopic preparation by 61%. Reduced-
laxative CTCwith threedosesof 20ml
40% barium sulphate is as effective as
more complex regimens, retaining
adequate diagnostic accuracy.
Keywords Colonography .
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Introduction
Full bowel purgation remains a major cause of discomfort
prior to any colonic investigation [1–3]. Furthermore, fluid
and electrolyte imbalance may occur following aggressive
cleansing [4]. A potential advantage of computed tomog-
raphy colonography (CTC) over colonoscopy is the ability
to reduce laxative requirements while maintaining diag-
nostic accuracy [5–7]. Reduced laxative regimens often
incorporate orally ingested contrast agents to “tag” or
“label” residual fluid and faecal residue. The ideal tagging
regimen remains controversial but must be safe, effective,
simple and well tolerated.
In many respects, barium is an ideal tagging agent: it has
an established safety profile, is relatively palatable,
produces minimal side effects, and is effective for tagging
solid residue [8]. Previous work has shown adequate
tagging may be achieved using low volumes of 40% w/v
barium, although the ideal volume and dosing regimen has
not been fully established [9]. Furthermore efficacy for
fluid tagging has been questioned [9], with some inves-
tigators preferring iodine-based contrast either alone or in
combination, claiming a more homogeneous fluid opaci-
fication better suited to digital subtraction [10]. We aimed
to establish the optimum barium-based reduced-laxative
faecal- and fluid-tagging regimen, to assess patient accept-
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Fax: +44-207-3882147ability, and to document diagnostic accuracy compared to
an enhanced colonoscopic reference standard.
Materials and methods
Full ethical committee approval was obtained, and all
subjects gave written informed consent.
Consecutive patients were recruited from those scheduled
to undergo afternoon diagnostic colonoscopy for symptoms
suggestive of colorectal neoplasia (change in bowel habit,
rectal bleeding, unexplained weight loss or palpable
abdominal mass) from one of three institutions. Patients
were excluded if below age 50 or if they had a known
diagnosis of inflammatory bowel disease. Eligible patients
were invited to undergo CTC at 8 am, prior to same day
colonoscopy and were randomised via a computer random
number generator to one of four reduced-laxative regimens
using barium-based faecal tagging [20 ml 40% w/v barium
sulphate suspension (Tagitol V, EZEM, Lake Success, NY)]
(Fig. 1). For each of the regimens, patients followed a low-
residue diet 2 days before the CTC (avoiding fatty food,
milk and vegetables). The day prior to CTC, all patients
were allowed a low-residue meal kit (Nutraprep, EZEM),
and ingested the same reduced-laxative protocol [13 g
sachet of senna granules (Reckitt Benckiser Healthcare,
Hull, UK) at 7 am and 18 g magnesium citrate (Lo-So prep,
EZEM) at 7 pm]. This laxative regimen was defined as
“reduced” given the normal laxative preparation prior to
colonoscopy at the recruiting institutions includes an
additional 18 g of magnesium citrate (see below). Overall
fluid intake was restricted to 2.1 l the day prior to CTC for
all four regimens.
In an attempt to improve fluid tagging, two regimens (C
andD)includedeitheranadditional250ml2.1%w/vbarium
sulphate (Readi-Cat Banana Smoothie, EZEM) or 15 ml
meglumine amidotrizoate (10 g sodium amidotrizoate/66 g
meglumine amidotrizoate per 100 ml; Gastrograffin, Scher-
ing) diluted in 250 ml of water, taken 2 h prior to CTC [11].
Patients otherwise took nothing by mouth the day of the
CTC.
Study power
The study was powered to detect a 20% difference in
tagging quality (see below) across the four regimens. Based
on pilot data, the interclass correlation coefficient between
colonic segments was calculated to be 0.30, and it was
calculated that a sample size of 22 per group was required
(alpha 0.05 at 80% power).
CT colonography
Prone and supine CTC was performed with automated CO2
insufflation (Protocol pump, EZEM) [12], using either a
4-detector-row (GE Lightspeed Plus, GE, Milwaukee, WI,
USA; 120 kV, 50 mA, 2.5 mm collimation, slice recon-
struction 1.25 mm, pitch 1.5, n=82 patients) or 64-detector-
row scanner (Siemens Somatom Sensation 64, SEMS,
Germany; 120 kV, 50 mA, 0.6 mm collimation, pitch 0.24,
n=13 patients).
One of three experienced radiologists (each with expe-
rience of at least 300 CTC cases with endoscopic
validation) evaluated the datasets immediately after the
examination using a dedicated workstation with propri-
etary software (Vitrea 3.8, Vital Images, Minnetonka, MN,
USA), and noted the segmental location of any polyps or
cancers on a study report sheet, together with lesion size
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Fig. 1 Details of reduced-
laxative tagging regimens.
Taken with meals from low
residue meal kit (single star).
Diluted in 250 mls of water
(double stars)
33measured using electronic callipers applied to the 2D MPR
best showing the maximum diameter. The choice of
reporting radiologist for each patient was dependent upon
the particular recruiting institution and availability on the
day of the scan. All three radiologists used a primary 2D
approach with 3D reserved for problem solving.
Colonoscopy
Immediately following CTC patients ingested a further
18 g of magnesium citrate in order to complete the normal
endoscopic cleansing regimen prior to afternoon colonos-
copy. Colonoscopy was performed as per usual practice by
one offive experienced endoscopists, on average 6h (range
4–8 h) after the CTC scan. Segmental unblinding was used
as described previously [13, 14], using the sealed CTC
report. In brief, the CTC report was handed to the
endoscopy nurse accompanying the patient. CTC findings
were revealed to the colonoscopist by the nurse on a
segmental basis (caecum to rectum) once examination of
each colonic segment was deemed complete during
extubation of the colon. If CTC suggested a lesion had
been missed, the segment was re-intubated and a second
segmental examination performed. There was no time limit
imposed on the colonoscopist for this second look. All
polyps were photographed, their sizes estimated by direct
comparison to adjacent open biopsy forceps, and then
excised for histology where possible.
Polyp correlation
Polyps found at CTC were deemed true positive if a
corresponding polyp was found in the same or adjacent
segment at endoscopy and if the estimated size of the polyp
was within 50% of the endoscopic measurement.
Patient experience
Immediately following CTC a questionnaire was adminis-
tered [15] investigating patient experience of the reduced-
laxative tagging regimen (Table 1). Patient responses were
compared to a historical cohort of 69 symptomatic patients
recruited from the same endoscopy lists during a prior
study comparing CTC to colonoscopy [16]. As part of this
prior study, patients had undergone full bowel preparation
[13 g senna granules and two doses of 18 g magnesium
citrate (total 36 g) prior to CTC] and had completed the
same questionnaire under similar circumstances.
One week later a follow-up questionnaire (Table 2)
was mailed to the current study cohort investigating
tolerance of the preparation prior to CT and preference, if
any, over the full preparation required for subsequent
colonoscopy.
Grading of bowel preparation
Two experienced radiologists (both with experience of over
700 validated CTC cases) in consensus retrospectively
reviewed all CTC examinations, grading the quality of
preparation and success oftagging.Observerswere unaware
of the tagging regimen used and divided the colon into six
segments (rectum to caecum) for analysis [17].
Grading of residual stool (irrespective of tagging status)
was based on the percentage of total mucosal circumfer-
ence coated on an axial image. For each colonic segment,
the slice with the most residual stool was used to assign the
score. Scores were as follows: 1: no residue or scattered
residue, 2: coating of <25% or thin circumferential “film”
less than 2 mm in depth, 3: coating of ≥25 to 50%, 4: >50%
coating.
Grading of residual fluid (irrespective of tagging status)
wasbasedonthemaximumanteroposterior(AP)diameterof
the colonic lumensubmerged.For eachcolonicsegment,the
slicewiththemostresidualfluidwasusedtoassignthescore.
Scoreswere asfollows: 1: nofluid,2: <25% APdiameter, 3:
≥25 to 50% AP diameter, 4: >50% AP diameter.
The quality of tagging for solid residue and fluid was
scored using a system adapted from Lefere at al. [9] and
assigned for supine and prone positions combined for each
colonic segment. Residual stool was divided into that
measuring ≤5 mm and ≥6 mm (based on 2D measurement
using electronic calipers), and the number of stool balls
≥6 mm was counted for each patient. Readers assessed the
percentage of total residual stool volume (for each size
category) that had been tagged for each colonic segment.
Scores were assigned as follows: 1: all residual stool
untagged, 2: 1 to <25% tagged, 3: 25 to <50% tagged, 4: 50
to <75% tagged, 5: 75 to 100% tagged.
Tagging of residual fluid was scored as follows: 1: fluid
untagged, 2: layered tagging (a mix of tagging densities in
one fluid level with a denser dependent layer and visibly
less dense non-dependent layer (Fig. 2), 3: fluid homo-
geneously tagged (single tagging density). The density of
tagged fluid (in HU) was also recorded by taking the
average of three regions of interest drawn in the deepest
fluid pool for each colonic segment. If fluid was layered
(Fig. 2), the minimum and maximum HU was recorded.
Finally observers recorded their confidence using a
percentage score that, based on the bowel preparation,
they would be able to exclude a polyp ≥6 mm in day-to-day
clinical practice for each colonic segment.
Statistical analysis
Preliminary data analysis revealed skewed data for most
bowel preparation and tagging variables, and thus scores
were combined for subsequent analysis. For residue, scores
weregroupedintoeitherascoreof1,orascoreof2ormore.
For residual fluid, scores were grouped into scores of 1/2, or
34scores of 3/4. Scores for solid residue tagging were grouped
intothoseof≤4or5.Fluidtaggingscores weregroupedinto
scores of 1/2, or score of 3. Logistic regression was then
applied, adjusting for colonic segment, to compare the four
regimens overall, and to compare the distal (rectum, sig-
moid, descending) and proximal colon (transverse, ascend-
ing and caecum). In addition, the prevalence of layering
within tagged fluid was compared on a per-patient basis
using the chi-squared test. Tagged fluid attenuation was
compared using linear regression following log transforma-
tion of the data. Confidence scores for excluding a polyp
≥6 mm were grouped as either <100% or 100%, and
compared using logistic regression. For all regression
analyses, robust standard errors were employed to account
for interdependency between colonic segments and scan
position (supine/prone) in the same patient. Results were
expressed as the odds of the outcome under consideration
compared to regimen A.
Table 1 Bowel-tolerance questionnaire questions and responses in comparison to historical controls undergoing full bowel preparation
Variable Response Reduced preparation
a,
n (%)
Historical controls
[full preparation]
b, n (%)
P value
How did you find
understanding prep sheet?
Easy 56 (63) 48 (70) 0.39
Fairly easy/difficult 33 (37) 21 (30)
How did you find
swallowing medicine?
Easy 43 (48) 44 (64) 0.36
Fairly easy 36 (40) 32 (32)
Quite difficult/difficult 10 (11) 3 (4)
How did you find coping
with special diet?
No problem 59 (66) 42 (61) 0.49
Bit difficult 24 (27) 24 (35)
Very difficult 6 (7) 3 (4)
How did you feel after
medicine?
Fine 65 (73) 48 (70) 0.96
Unwell/very unwell 24 (27) 21 (30)
Did you have
any abdominal pain?
None 31 (36) 25 (36) 0.37
Mild 39 (45) 27 (39)
Moderate/severe 16 (19) 17 (25)
Did you have any
nausea/vomiting?
None 58 (67) 46 (67) 0.92
Mild 22 (26) 18 (26)
Moderate/severe 6 (7) 5 (7)
Did you experience any
faintness or dizziness?
None 70 (81) 54 (78) 0.63
Mild/moderate/severe 16 (29) 15 (22)
Did you experience
any wind?
None 25 (29) 26 (38) 0.27
Mild 41 (48) 32 (46)
Moderate/severe 20 (23) 11 (16)
Did you experience any
soreness?
None 37 (43) 24 (35) 0.15
Mild 37 (43) 29 (42)
Moderate/severe 12 (14) 16 (23)
Did you experience any
incontinence?
None 68 (80) 49 (71) 0.2
Mild 8 (9) 13 (19)
Moderate/severe 9 (11) 7 (10)
Did you experience any
sleep disturbance?
None 33 (39) 41 (59) 0.01
Mild 29 (34) 20 (29)
Moderate/severe 23 (27) 8 (12)
How many times did you
open your bowel after starting
the preparation?
1–3 1 (1) N/A
3–5 20 (22)
>5 69 (77)
N/A Not applicable (not asked)
a13 g senna plus 18 g magnesium citrate
b13 g senna plus 36 g magnesium citrate
35Questionnaire responses were compared using Fischer’s
exact test.
Overall categorical per-polyp and per-patient data are
presented using descriptive statistics. Given the relatively
low polyp incidence (and thus low statistical power),
comparative statistics for polyp detection were not
performed across regimens. False-positive numbers were
compared using one-way ANOVA.
Results
A total of 95 patients were recruited (50 female, mean age
64 years, range 50–85 years), with 24, 25, 24 and 22
randomised to regimens A to D respectively. Seventy-seven,
13 and 5 patients were recruited from institutions 1, 2 and 3
respectively. Overall, 67 (71%) had a change in bowel habit,
18(19%)hadrectalbleeding,7(7%)hadnon-specificweight
loss, and 3 (3%) had a clinically palpable abdominal mass.
Bowel preparation
The percentage of segments (supine and prone combined)
assigned a score of 1 for residual solid residue (i.e. no
residue or scattered) was 76% (218/288), 82% (246/300),
81% (232/288) and 94% (247/264), for regimens A to D
respectively,andon average there were2.5, 2.0, 2.8 and1.1
stool balls ≥6 mm per patient. The improved quality of
preparation in regimen D reached statistical significance
[odds of score 2–4: 0.19 (95% CI: 0.07, 0.56), P=0.02].
Across all regimens, the distal colon was significantly
better prepared then the proximal colon (P=0.006). For
example the number of segments assigned at least a score
of 2 for solid residue in the caecum was 42% (20/48), 48%
Table 2 Questions and responses to follow-up questionnaire pertaining to patient tolerance and preferences
Variable Response Patient number (%)
How did you find
taking the low-residue
diet?
No problem 46 (67%)
Moderately inconvenient 20 (29%)
Very inconvenient 3 (4%)
How did you find
drinking the tagging
liquid?
No problem 57 (83%)
Moderately inconvenient 11 (16%)
Very inconvenient 1 (1%)
How did you tolerate
the preparation
before CT?
Well 37 (53%)
Fairly well 29 (42%)
Poorly 3 (4%)
How did you tolerate
the additional preparation
prior to colonoscopy,
compared to that before
the CT?
No problem 51 (74%)
More uncomfortable 12 (17%)
Much worse 6 (9%)
How did you find the
preparation before CTC
compared to the full
colonoscopy preparation?
Much better 18 (26%)
Better 24 (35%)
No better 26 (38%)
Fig. 2 A 68-year-old female with change in bowel habit. Axial CT
colonographic image demonstrating layering of contrast (arrow)
within tagged fluid
36(24/50), 35% (17/48) and 23% (10/44) for regimens A to D
respectively, compared to 25% (12/48), 16% (8/50), 21%
(10/48) and 0% (0/44) for the rectum.
The percentage of segments (supine and prone in total)
assigned a score of 1 or 2 for residual fluid was 51%
(148/288), 59% (178/300), 53% (153/288) and 43%
(114/264) for regimens A to D respectively. There was
no significance difference between groups either overall or
between the proximal and distal colon (P=0.22–0.37).
Tagging quality
Tagging quality was generally good (mean tagging score
3.7–4.5) (Fig. 3). While there was weak evidence of
improved proximal colonic tagging for residue ≤5 mm for
regimens C and D (P=0.08), overall there was no
difference in the efficacy of solid residue tagging across
regimens (Table 3).
The average per-segment fluid tagging score was 2.5
(SD 0.8), 2.3 (SD 1.0), 2.5 (SD 0.9) and 2.4 (SD 1.2) for
regimens A to D respectively. The odds of homogeneous
tagging (i.e score 3) did not differ across the four regimens
either overall or between the proximal and distal colon
(P=0.65–0.95). In total, 4% (6/144), 1% (2/150), 2%
Fig. 3 A 54-year-old male with unexplained rectal bleeding. Axial
CT colonographic image showing homogeneous tagging of stool
≤5m m( arrow) and ≥6m m( arrowhead) in size
Table 3 Efficacy of tagging of
solid residue according to size
and regimen
SD Standard deviation
aOdds of tagging score of 5
(best) compared to regimen A
bRectum, sigmoid and descend-
ing colon combined
cTransverse, ascending colon
and caecum combined
Solid residue size Colon segments Regimen Mean tagging score (SD) Odds ratio (95% CI)
a P value
≤5 mm All segments A 4.3 (1.2) 1
B 4.3 (1.2) 0.94 (0.39, 2.32)
C 4.5 (1.1) 1.47 (0.56, 3.87)
D 4.5 (1.2) 1.67 (0.68, 4.14) 0.56
Distal colon
b A1
B 0.97 (0.37, 2.52)
C 0.76 (0.26, 2.27)
D 1.00 (0.38, 2.61) 0.97
Proximal colon
c A1
B 0.85 (0.26, 2.80)
C 4.06 (0.74, 22.1)
D 3.22 (0.95, 10.9) 0.08
≥6 mm All segments A 4.1 (1.6) 1
B 4.3 (1.5) 1.82 (0.44, 7.62)
C 4.1 (1.7) 1.56 (0.32, 7.76)
D 3.7 (1.8) 0.43 (0.11, 1.65) 0.24
Distal colon
b A1
B 1.30 (0.26, 2.52)
C 3.84 (0.37, 39.2)
D 0.17 (0.02, 1.27) 0.12
Proximal colon
c A1
B 3.22 (0.26, 39.8)
C 0.94 (0.11, 7.87)
D 0.91 (0.11, 7.54) 0.78
37(3/144) and 5% (6/132) of segments respectively contained
non-tagged fluid (score 1) (Fig. 4).
Overall 33% (8/24), 44% (11/25), 38% (9/24) and 36%
(8/22) of patients receiving regimens A to D respectively
had at least one segment with layering of tagged fluid
(P=0.89) (Fig. 2).
Fluid tagging density
In terms of mean HU of the tagged fluid (excluding the
least tagged layer if tagging was layered), there was no
significant difference among the four regimens, either
overall or between the proximal/distal colon (P=0.14–
0.86). The mean HU of tagged fluid was 522 (SD 283), 504
(SD 395), 430 (SD 268), and 491 (SD 269) for regimens A
to D respectively.
However in those segments with layering of contrast, the
maximum attenuation (HU) of the least tagged layer was
significantly higher for regimens C and D than for regimens
A and B (P=0.002) [77 (SD 105), 119 (SD 139), 155 (SD
118) and 174 (SD 122), for regimens A to D respectively].
Patient experience
A total of 89 of 95 (94%) patients completed the
questionnaire (Table 1), although responses were incom-
plete in 4. Demographic data for the present study cohort
(50 female, mean age 64 years, range 50–85 years) were
not significantly different from the 69 historical controls
(36 female, mean 63 years, range 35–85 years) [16]. Other
than sleep disturbance (worse after reduced preparation)
(P=0.01), there was no significant difference in reported
tolerance of the reduced and full bowel preparation
regimens for any of the factors tested.
Follow-up questionnaire
Sixty-nine (73%) patients returned the follow-up ques-
tionnaire (Table 2). Overall 95% tolerated the reduced
preparation regimen well or fairly well, and most (83%)
found drinking the tagging agents acceptable. Although
most [51/69 (74%)] found the additional preparation
required for colonoscopy “no problem”, a majority (61%)
found the reduced preparation regimen “better” or “much
better” than the full preparation required for colonoscopy.
Diagnostic performance
Five patients (one each from regimens A, B, and C and two
from regimen D) were excluded from the performance
analysis due to a new diagnosis of inflammatory bowel
disease (all presenting with rectal bleeding). A further
patient (from regimen B) was excluded after refusing
colonoscopy. Of the remaining 89 patients, 68 had either
normal colonoscopy or diminutive polyps (≤5 mm) only,
and 21 had at least one polyp ≥6 mm or cancer.
Colonoscopy was incomplete in 10/89 (11%) reaching
the transverse colon in 6, sigmoid in 3 and hepatic flexure
in 1. Reasons for failure were obstructing stricture (1),
severe diverticulosis (1), tortuous colon (5), and pain (3).
Only those segments visualised at colonoscopy were
included in the assessment of diagnostic performance.
Fig. 4 A 75-year-old female with change in bowel habit. Axial CT
colonographicimageshowingfailureoffluidtagging(arrow)(grade1)
Fig. 5 A 71-year-old male with rectal bleeding. Axial CT
colonographic image demonstrating a 30-mm rectal cancer
(arrow). Note the adjacent well-tagged residue (arrowheads)
38Per polyp analysis
In total there were 9 polyps ≥10 mm (all adenomatous), 12
polyps 6–9 mm (10 adenomatous, 2 hyperplastic) and 72
polyps≤5mm(46wererecoveredforhistology,ofwhich26
were adenomatous, 15 hyperplastic and 5 normal mucosa).
One 6-mm polyp and two 5-mm polyps were found only on
re-look endoscopy after segmental unblinding of the CTC
report. No CTC-detected polyps were classified as false
positives due to segmental or size mismatching with
colonoscopy.
SummedacrossregimensA–D,detectionofcancer,polyps
≥10 mm, 6–9m ma n d≤5 mm was 2/2 (100%), 8/9 (89%),
9/12(75%)and23/72(32%)respectively(Fig.5)(T able4).In
total there were only four false positives ≥6m m( F i g s .6 and
7),withnosignificantdifferencebetweenregimens(P=0.15).
Per patient analysis
Across all regimens sensitivity, specificity, positive and
negative predictive values for detection of patients with any
lesion ≥6 mm were 96%, 97%, 0.9 and 0.96 respectively
(Table 5).
Reader confidence
The mean segmental observer confidence for excluding a
polyp ≥6 mm was 90, 89, 97 and 93% for regimens A to D
respectively. There was no significant difference among the
regimens, either overall or in the proximal/distal colon
(P=0.15–0.57).
Discussion
In accordance with previous studies [6, 8, 10], we found
patients in general preferred reduced preparation to the full
Fig. 7 Overall number of false positives according to size and
regimen (n=89)
Table 4 Polyp detection overall and according to tagging regimen
Regimen Patient
number
Detection
cancer, n (%)
Detection
10 mm+, n (%)
Detection 6–
9 mm, n (%)
Detection 1–
5 mm, n (%)
False positive
10 mm+, n
False positive
6–9 mm, n
False positive
1–5 mm, n
P
value
a
A 23 2/2 (100%) 1/2 (50%) N/A 3/10 (30%) 0 1 7 0.15
B 23 N/A 3/3 (100%) 5/6 (83%) 10/30 (33%) 0 1
b 9
C 23 N/A 1/1 (100%) 2/2 (100%) 6/20 (30%) 0 0 1
D 20 N/A 3/3 (100%) 2/4 (50%) 4/12 (33%) 1
c 12
Overall 89 2/2 (100%) 8/9 (89%) 9/12 (75%) 23/72 (32%) 1 3 19
N/A Not applicable
aComparison of false positives across regimens using one-way ANOVA
bIn patient with confirmed 8-mm polyp
cIn patient with confirmed 10-mm polyp
Fig. 6 A 54-year-old male with change in bowel habit. Axial CT
colonographic image of a 6-mm filling defect in the rectum reported
as a polyp. No lesion was found at colonoscopy with segmental
unblinding suggesting the lesion was untagged faecal residue
39purgation required for colonoscopy, although this pref-
erence was much less than expected (only 61% preferred
the reduced preparation). We defined the laxation used as
“reduced” in comparison to the endoscopic preparation
used at our institutions which includes an additional 18 g of
magnesium citrate. We also used senna rather than
bisacodyl as used by Lefere et al. [9]. Both are stimulant
laxatives with a similar mode of action and effect at the
doses administrated, although senna was preferred as it is
widely used at our institutions. However a combination of
13 g of senna and 18 g magnesium citrate clearly produces
relatively strong purgation, reflected in the induced symp-
toms (77% of patients opened their bowels over five times)
and marginal patient preference. It would therefore seem
reasonable to study reduced laxation further, perhaps
omitting the senna and/or reducing the dose of magnesium
citrate. It is however important to realise that whereas
normally patients took no solids by mouth for 24 h prior to
colonoscopy, in the present study they were permitted to
eat from a low-residue diet kit, an issue we did not
specifically address with our questionnaires, thereby
potentially underestimating this benefit.
Recent data have questioned whether CTC is actually
better tolerated than conventional colonoscopy [18], but
because full bowel purgation is often cited by patients as
the worst part of any colonic examination [1, 2], it is
assumed that reduced laxative CTC will improve patient
compliance (notably in a screening setting). However this
assumption has not been proven in prospective trials, and
we cannot extrapolate the preferences we found into
increased compliance with CTC. Indeed it could be argued
the laxative regimen we used would have relative little
impact on compliance in a screening setting, given the side-
effect profile.
The overall quality of bowel preparation was good, with
all four regimens producing at least 76% of segments with
either no or scattered residue only. This is similar to data
reported by Lefere et al. [9], who combined 16.5 g of
magnesium citrate with biscodyl tablets and suppository.
Interestingly, regimen D, which included 15 ml meglumine
amidotrizoate, resulted in significantly better preparation
than the other regimens, possibility due to a “washing
effect” of the iodine-based contrast, incorporating solid
residue into a more fluid solution [10]. Although we used a
small dose, meglumine amidotrizoate is also known to
have a laxative effect that may also have added to the
superior cleansing.
Tagging of solid residue was in general good, with no
significant difference between the regimens tested. This
suggests barium-based tagging can be simplified to a 1-day
regimen only, when combined with reduced cathartic
preparation. Similarly all regimens produced an average
tagged fluid density of around 500 HU. Recent phantom
data suggest that although submerged polyp conspicuity is
optimised at 700 HU, it remains good at 500 HU [19]. We
did however demonstrate that fluid tagging could be
manipulated by additional oral agents on the morning of
CTC. As it is non-miscible with water, barium often pro-
duces a layering effect with lower attenuation fluid sitting
above denser barium. Although there was no significant
difference in layering among the regimens, the addition of
morning 2.1% barium sulphate or meglumine amidotrizo-
ate significantly increased the attenuation of the non-
dependent fluid layer. It is arguable whether this will have
significant impact clinically, not least because fluid moves
between supine and prone positions, but it may have
implications for subtraction software. Zalis et al. have
recently demonstrated suboptimal subtraction when high-
density barium is used as the sole tagging agent [10]. It is
Table 5 Per-patient performance overall and according to tagging regimen
Regimen Patient
number
Polyp ≥6 mm incl. cancer, n (%) [95% confidence limits] Polyp ≥10 mm incl. cancer, n (%) [95% confidence limits]
Sensitivity Specificity PPV NPV Sensitivity Specificity PPV NPV
A 23 3/4 (75%)
[33–100%]
18/19 (95%)
[85–100%]
0.75 0.95 3/4 (75%)
[33–100%]
19/19 (100%)
[100–100%]
1.0 0.95
B 23 7/7 (100%)
[100–100%]
16/16 (100%)
[100–100%]
1.0 1.0 3/3 (100%)
[100–100%]
20/20 (100%)
[100–100%]
1.0 1.0
C 23 3/3 (100%)
[100–100%]
20/20 (100%)
[100–100%]
1.0 1.0 1/1 (100%)
[100–100%]
22/22 (100%)
[100–100%]
1.0 1.0
D 20 5/7 (71%)
[38–100%]
12/13 (93%)
[78–100%]
0.83 0.86 3/3 (100%)
[100–100%]
17/17 (100%)
[100–100%]
1.0 1.0
Overall 89 18/21 (96%)
[93–100%]
66/68 (97%)
[93–100%]
0.9
a 0.96 10/11 (91%)
[74–100%]
78/78 (100%)
[100–100%]
1.0
b 0.99
NPV Negative predictive value, PPV positive predictive value
aPrevalence of abnormality=0.24
bPrevalence of abnormality=0.12
40interesting to speculate whether manipulation of fluid
tagging could optimise subtraction. It should also be noted
our regimen mildly restricted fluid intake the day prior to
CTC, which may have influenced our fluid tagging results.
One major advantage of barium as a tagging agent is its
inertnatureandsafety.Althoughiodinatedcontrastmedium
producesmorehomogeneousfluidtagging,thisismainlyof
clinical importance if subtraction software is being used.
While the risks of allergy to oral iodinated contrast are
minimal,adverseeventsdooccur[20,21].Ourdatasuggest
good results can be achieved using only barium.
Ultimately, diagnostic performance is the best measure
of the success of any reduced-laxative protocol. Reassur-
ingly overall, we prospectively found high diagnostic
performance when compared to colonoscopy. Our data
confirm again that full bowel preparation is not required to
maintain diagnostic accuracy for CTC, assuming adequate
reader training [22]. Importantly, there were only four false
positive polyps over 6 mm, and across all regimens the
positive predictive value for patients with any lesion
≥6 mm and ≥10 mm was 0.9 and 1.0 respectively (Table 5).
Our study does have weaknesses. It could be argued that
we used a relatively harsh laxative regime given that good
results have been reported without any laxative at all [5,
6]. However the vast majority of CTC worldwide is still
performed using full bowel preparation, and in the
authors’ opinion, significant changes in practice are most
likely to follow gradual reduction of purgation, which
allows radiologists to become comfortable with this
approach. However we acknowledge that if there was
good evidence of acceptable performance data using CTC
without prior laxation, this may well rapidly become
widely implemented by the CTC community. We
compared patient symptomatology with a historical
cohort, and although well-matched in demographic
terms, we cannot exclude bias completely. We did not
instruct colonoscopists to grade the quality of bowel
preparation and, in particular, the influence of retained
barium on mucosal visibility, although no endoscopy
failed due to incomplete bowel preparation. It could be
argued that reduced preparation regimens are best suited to
increase compliance in asymptomatic screening popula-
tions [23]. However for pragmatic reasons we used
symptomatic patients, as we do not have access to a
large screening population. Finally, although we were able
to show high diagnostic performance for reduced-prepa-
ration CTC overall, given the relatively low number of
polyps, we were unable to meaningfully compare across
regimens.
In conclusion, a combination of reduced laxatives and a
simple tagging regimen based on 40% barium sulphate the
day prior to CTC maintains acceptable diagnostic accuracy.
Three doses of 20 ml 40%w/v barium sulphate are as
effective as more complex regimens, but fluid tagging can
be manipulated by addition of dilute barium or meglumine
amidotrizoate on the morning of CTC, the latter also
reducing the volume of residual stool.
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